We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$282M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
| 3 |
ConocoPhillips
COP
|
+$203M |
| 4 |
Fortive
FTV
|
+$200M |
| 5 |
Merck
MRK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$665M |
| 2 |
ExxonMobil
XOM
|
+$332M |
| 3 |
Burlington
BURL
|
+$242M |
| 4 |
National Vision
EYE
|
+$186M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.03% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Atmos Energy
ATO
$28.7B
| $13.8M | 0.03% |
140,104
+1,278
| +0.9% | +$116K |
|
577
ACV Auctions
ACVA
$1.3B
| $13.8M | 0.03% |
+400,000
| New | +$12.8M |
|
578
Eastern Bankshares
EBC
$5.27B
| $13.8M | 0.03% |
713,998
-51,002
| -7% | -$887K |
|
|
QELL
579
DELISTED
Qell Acquisition Corp. Class A Ordinary Shares
QELL
| $13.7M | 0.03% |
1,350,000
-1,150,000
| -46% | -$13.9M |
|
580
Allegro MicroSystems
ALGM
$7.91B
| $13.7M | 0.03% |
541,467
+7,764
| +1% | +$222K |
|
|
SRRA
581
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $13.6M | 0.03% |
+789,829
| New | +$12.5M |
|
|
AEAC
582
DELISTED
Authentic Equity Acquisition Corp. Class A ordinary share
AEAC
| $13.6M | 0.03% |
+1,400,000
| New | +$13.6M |
|
583
Coursera
COUR
$1.59B
| $13.5M | 0.03% |
+300,000
| New | +$13.5M |
|
584
Praxis Precision Medicines
PRAX
$10.3B
| $13.5M | 0.03% |
27,472
| – | – |
|
585
Bio-Rad Laboratories Class A
BIO
$9.16B
| $13.5M | 0.03% |
23,620
+230
| +1% | +$136K |
|
586
Live Nation Entertainment
LYV
$42.3B
| $13.4M | 0.03% |
158,560
-644
| -0.4% | -$51.8K |
|
587
Brown-Forman Class B
BF.B
$13B
| $13.4M | 0.03% |
193,932
-3,800
| -2% | -$278K |
|
588
Monolithic Power Systems
MPWR
$66.8B
| $13.4M | 0.03% |
+37,800
| New | +$13.8M |
|
589
Synaptics
SYNA
$3.99B
| $13.3M | 0.03% |
+98,500
| New | +$12M |
|
590
Fox Class A
FOXA
$25.9B
| $13.3M | 0.03% |
+369,373
| New | +$12.9M |
|
|
GRTX
591
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $13.3M | 0.03% |
1,509,500
| – | – |
|
592
LKQ Corp
LKQ
$6.19B
| $13.2M | 0.03% |
311,200
+6,100
| +2% | +$240K |
|
593
Host Hotels & Resorts
HST
$16B
| $13.2M | 0.03% |
780,533
+35,300
| +5% | +$552K |
|
|
SBNY
594
DELISTED
Signature Bank
SBNY
| $13.1M | 0.03% |
57,952
+47,952
| +480% | +$9.45M |
|
|
BLSA
595
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $13.1M | 0.03% |
1,237,500
| – | – |
|
596
Roku
ROKU
$22.3B
| $13M | 0.03% |
+40,000
| New | +$15.7M |
|
597
Kennametal
KMT
$2.58B
| $13M | 0.03% |
+326,000
| New | +$12.7M |
|
598
American Water Works
AWK
$26.8B
| $13M | 0.03% |
86,833
-111,300
| -56% | -$16.9M |
|
599
Alcoa
AA
$12.5B
| $13M | 0.03% |
+400,000
| New | +$10.1M |
|
600
Tyler Technologies
TYL
$12.5B
| $13M | 0.03% |
30,600
-3,300
| -10% | -$1.43M |
|
Similar funds
Adage Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
- Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
- Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
- Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
- Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
- Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
- Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.
Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.